APA

Heslop K. A., Rovini A., Hunt E. G., Fang D., Morris M. E., Christie C. F., Gooz M. B., DeHart D. N., Dang Y., Lemasters J. J. & Maldonado E. N. (20200727). JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells. : Biochemical pharmacology.

Chicago

Heslop K A, Rovini A, Hunt E G, Fang D, Morris M E, Christie C F, Gooz M B, DeHart D N, Dang Y, Lemasters J J and Maldonado E N. 20200727. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells. : Biochemical pharmacology.

Harvard

Heslop K. A., Rovini A., Hunt E. G., Fang D., Morris M. E., Christie C. F., Gooz M. B., DeHart D. N., Dang Y., Lemasters J. J. and Maldonado E. N. (20200727). JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells. : Biochemical pharmacology.

MLA

Heslop K A, Rovini A, Hunt E G, Fang D, Morris M E, Christie C F, Gooz M B, DeHart D N, Dang Y, Lemasters J J and Maldonado E N. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells. : Biochemical pharmacology. 20200727.